choline-tmao-pathway

Searcher 7 orientation — Choline → TMAO pathway

Slice: the choline (egg phosphatidylcholine) → gut-microbiota TMA → hepatic TMAO → proposed pro-atherogenic/pro-thrombotic pathway, as a cardiovascular-harm mechanism independent of the blood-lipid pathway. 10 sources written (budget: 10), all read properly at primary-source level (plus 2 meta-analyses skimmed as hubs, ~well within the ~20-read budget once hub-skimming is counted).

Sources by topic (best-first within each)

Foundational mechanism + TMAO-predicts-events (all Hazen-lab, Cleveland Clinic):

1. S-28 - Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease (Wang et al. 2011, Nature).md — root paper: identifies choline/TMAO/betaine, mouse atherosclerosis mechanism, first human predictive cohort.
2. S-29 - Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk (Tang et al. 2013, NEJM).md — the egg/PC challenge (2 hard-boiled eggs) + antibiotic-suppression proof + 4,007-patient prospective MACE cohort.
3. S-40 - Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk (Zhu et al. 2016, Cell).md — second mechanism (pro-thrombotic, platelet), same cohort reproduces events link.
4. S-39 - Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis (Koeth et al. 2013, Nature Medicine).md — analogous carnitine→TMAO route (red meat, not eggs); included per brief as related foundational context, not egg-specific.

Does eating eggs actually raise TMAO (feeding studies): 5. S-47 - Effect of egg ingestion on trimethylamine-N-oxide production in humans- a randomized, controlled, dose-response study (Miller et al. 2014, AJCN).md — yes, acutely/postprandially, dose-dependent (0/1/2/4 eggs). 6. S-48 - Intake of up to 3 eggs-day increases HDL cholesterol and plasma choline while plasma TMAO is unchanged in a healthy population (DiMarco et al. 2017, Lipids).md — chronic (12-wk) feeding, fasting TMAO unchanged despite dose-dependent choline rise. Dual-headline with lipids (HDL) — flagged for the consolidator to check slice 4/5 hasn’t independently minted it. 7. S-59 - Effects of egg consumption and choline supplementation on plasma choline and TMAO in a young population (Lemos et al. 2018, J Am Coll Nutr).md — eggs vs. choline-bitartrate supplement, both null on fasting TMAO in this (UConn/Cornell) lab. 8. S-60 - Dietary choline supplements, but not eggs, raise fasting TMAO levels in participants with normal renal function- a randomized clinical trial (Wilcox et al. 2021, Am J Med).md — from the Hazen/Tang lab itself: eggs and PC capsules null, free choline-bitartrate positive. Cross-lab tension vs. #7 (Lemos found the supplement null too) is worth downstream attention.

Skeptical side (marker-not-cause / relative-dose context): 9. S-68 - TMAO response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition (Cho et al. 2016-2017, Mol Nutr Food Res).md — fish raises TMAO 46-62x more than eggs/meat, with no corresponding fish-CVD harm in the broader literature. 10. S-69 - TMAO is associated with mortality- impact of modestly impaired renal function (Gruppen et al. 2017, Scientific Reports).md — independent Dutch general-population cohort (PREVEND): the TMAO-mortality association is substantially explained by eGFR/renal function, not independent of it.

search_scope

WebSearch (until the session’s search-tool budget was exhausted mid-task, at which point I switched to WebFetch + direct API/Bash calls) for each named anchor in the brief plus forward/backward snowballing; OpenAlex API (api.openalex.org/works) for citation counts, dates, and full author lists (more complete than Semantic Scholar, which undercounted e.g. Koeth 2013 by ~18x); NCBI E-utilities (esearch/esummary/efetch against PubMed) to pin down exact citations and abstracts once titles were known (used for Heianza 2017, DiMarco 2017, Lemos 2018); one WebFetch of a skeptical commentary (Klatt & Caudill, amj.amegroups.org, “Pressing the trimethylamine N-oxide narrative”) used as an informal hub to confirm the fish-vs-egg comparison and the marker-vs-cause framing. Discovery hubs mined (not minted): Heianza et al. 2017 JAHA (doi 10.1161/JAHA.116.004947, ~19 prospective studies, TMAO+precursors → MACE/mortality meta-analysis) and Schiattarella et al. 2017 Eur Heart J (doi 10.1093/eurheartj/ehx342, 17 studies/26,167 subjects, TMAO → mortality/MACCE dose-response meta-analysis).

exclusions

• Wang Z et al. 2014, Eur Heart J, “Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide” (doi 10.1093/eurheartj/ehu002, ~562 citations) — found via the same citation network as Tang 2013/Zhu 2016; NOT minted because it reuses the same Cleveland Clinic GeneBank angiography cohort as Tang 2013 and Zhu 2016 (already in this pool) — minting it would pad the pool with a third analysis of one dataset rather than adding independent data. Noted here for step 2/5 in case they want the choline/betaine-specific numbers.
• Zhu C. et al. ~2019/2021 (Nutrition Research / FASEB abstract), “Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women” — a fourth null-egg-TMAO chronic feeding study, in a distinct (older, postmenopausal) population. Not minted: budget (10 writes) was fully used by the three null studies already minted (DiMarco 2017, Lemos 2018, Wilcox 2021), which are more central (younger/general population, closer to the brief’s named anchors, and Wilcox is the against-own-hypothesis Hazen-lab result). Flagging as a gap — a genuine independent population (postmenopausal, where renal function/age-related TMAO elevation is more relevant) that a future pass could add.
• Mendelian-randomization evidence on TMAO and cardiometabolic disease — real and relevant to the marker-vs-cause thread (search turned up generic secondary discussion that genetically predicted TMAO is not associated with elevated CVD/T2D risk, and that reverse causality — kidney disease/insulin resistance raising TMAO — may run the other way), but I could not pin down a single clean primary MR paper (title/DOI) before the WebSearch budget for this session was exhausted. This is a real gap for the skeptical thread; worth a targeted follow-up search (“Mendelian randomization TMAO FMO3 coronary artery disease”) in step 2 or a later pass.
• Did not touch, and record here only for completeness: any study whose headline biomarker is blood lipids (slices 4/5 territory — DiMarco 2017 is the one boundary case I minted here, since its TMAO-null finding is co-headline and central to this slice); choline as a beneficial/essential nutrient, neurodevelopment, or adequacy (slice 8 territory); egg-diabetes literature (slices 3/6); hard-event egg-intake cohorts not going through the TMAO mechanism (slices 1/2); methodology/substitution critiques (slice 9).

Slice shape

A tight, well-defined mechanistic literature: essentially one lab (Hazen/Tang, Cleveland Clinic) originated and still dominates the foundational harm-pathway claim (S-28, S-29, S-39, S-40 — all four share several co-authors), which is a genuine independence concern the consolidator should weigh (these are related but not fully independent studies of overlapping cohorts/investigators, not four separate confirmations). The egg-feeding literature on TMAO specifically is smaller and more mixed than I expected going in: one dose-response study finds an acute rise (Miller 2014), but three separate chronic-feeding RCTs — including one from the Hazen/Tang lab itself — find no fasting-TMAO change from eggs, with TMAO rising only when choline is given as a free/bitartrate supplement rather than via whole eggs or phosphatidylcholine capsules. This acute-vs-chronic and food-matrix-vs-supplement distinction is, in my view, the single most important nuance this slice surfaces for the main question: the mechanistic case that eggs (specifically, as opposed to purified choline) meaningfully raise steady-state TMAO is weaker than the foundational papers’ egg-challenge framing suggests. I went looking for, and could not pin down, a clean Mendelian-randomization primary on TMAO causality (a gap, noted above), and did not find a dedicated study directly modeling whether higher-TMAO individuals who eat more eggs actually have worse hard outcomes than higher-TMAO individuals from other diets — that link is left to step 5’s cross-slice work once the hard-endpoint (slices 1/2/3) and this slice’s evidence-links are both in the graph.